At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Varisolve Polidocanol Endovenous Microfoam (PEM) 0.5% and 1% Compared to Vehicle for the Treatment on Saphenofemoral Junction (SFJ) Incompetence "VANISH-2"
In Brief
A Phase 3 clinical trial evaluating polidocanol injectable foam, 0.125%, polidocanol injectable foam, 0.5%, and 2 other interventions for Varicose Veins. Completed, enrolled 235 participants across 12 sites.
Detailed Summary
Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of three different concentrations of an investigational drug, Polidocanol Endovenous Microfoam (PEM) compared to vehicle (inactive solution) in treating the symptoms and appearance of varicose veins.
Study Details
Timeline
Interventions
active placebo for blinding
0.5% polidocanol foam injection
1.0% polidocanol foam injection
injection of vehicle comparator